Opioid Dependence News and Research

RSS
SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

Study identifies factors linked to disengagement from treatment for opioid use disorder

Study identifies factors linked to disengagement from treatment for opioid use disorder

Opioid users treated in compulsory drug detention centre more likely to relapse, study shows

Opioid users treated in compulsory drug detention centre more likely to relapse, study shows

New study finds opioid dependence affects perception of cute images of babies

New study finds opioid dependence affects perception of cute images of babies

Buprenorphine implants could be effective option to treat adults with opioid dependence

Buprenorphine implants could be effective option to treat adults with opioid dependence

Study identifies persistent opioid use in some patients after knee or hip replacement

Study identifies persistent opioid use in some patients after knee or hip replacement

First buprenorphine implant for opioid dependence treatment gets FDA approval

First buprenorphine implant for opioid dependence treatment gets FDA approval

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

Women need different treatment from men with addiction, says McMaster University-led study

Women need different treatment from men with addiction, says McMaster University-led study

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

FDA accepts Braeburn's resubmission of Probuphine NDA for review

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Variations in opioid receptor genes linked to neonatal abstinence syndrome severity in newborn babies

Variations in opioid receptor genes linked to neonatal abstinence syndrome severity in newborn babies

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

People across the world are living longer but spending more time in ill health

People across the world are living longer but spending more time in ill health

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

BioDelivery Sciences secures additional $20.7M in gross debt funding from MidCap Financial

BioDelivery Sciences secures additional $20.7M in gross debt funding from MidCap Financial

BioDelivery Sciences calls for new treatment options for opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction

Total costs of treatment for babies with neonatal abstinence syndrome on the rise

Total costs of treatment for babies with neonatal abstinence syndrome on the rise